Wenyan Miao is a seasoned biopharmaceutical professional with extensive experience in immunology and biochemistry. Currently serving as the VP of the CSO Partner Team at Curie.Bio since June 2024, Wenyan has previously held senior leadership roles, including VP of Immunology at ROME Therapeutics and VP of Immunology & Inflammation at Celsius Therapeutics. Experience also includes significant positions such as Executive Director of Immunology at Nimbus Therapeutics and Senior Director of Molecular and Cell Biology at Repligen Corp. Wenyan's early career featured roles at Pfizer Inc., Abbott Bioresearch Center, Millennium Pharmaceuticals, and LeukoSite, culminating in a postdoctoral fellowship. Wenyan earned a PhD in Biochemistry and Molecular Biology from Indiana University School of Medicine.